Vericel Corporation Logo
Vericel to Present at Canaccord Genuity and ARM Investor Conferences
March 18, 2015 08:51 ET | Vericel Corporation
CAMBRIDGE, Mass., March 18, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...
Vericel Corporation Logo
Vericel to Host Fourth-Quarter 2014 Earnings Call on March 23, 2015
March 12, 2015 16:30 ET | Vericel Corporation
CAMBRIDGE, Mass., March 12, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...
Vericel Corporation Logo
Vericel to Present at 27th Annual ROTH Conference
March 06, 2015 07:30 ET | Vericel Corporation
CAMBRIDGE, Mass., March 6, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...
Vericel Corporation Logo
Vericel Completes Patient Enrollment in Phase 2b ixCELL-DCM Clinical Study of Ixmyelocel-T
January 29, 2015 08:45 ET | Vericel Corporation
CAMBRIDGE, Mass., Jan. 29, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...